LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 3.21 | 770.25 | 898 | 904 | 0.9927 | 0.9376 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.44 | 770.25 | 854 | 1012 | 0.8433 | 0.2987 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 5.44 | 770.25 | 1021 | 1012 | 1.0081 | 1.0415 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.66 | 770.25 | 933 | 1090 | 0.8560 | 0.4662 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 7.66 | 770.25 | 1090 | 1090 | 1.0000 | 1.0000 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.06 | 770.25 | 1041 | 1218 | 0.8543 | 0.5765 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 10.06 | 770.25 | 1197 | 1218 | 0.9824 | 0.9469 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.28 | 770.25 | 1142 | 1358 | 0.8409 | 0.6182 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 12.28 | 770.25 | 1314 | 1358 | 0.9675 | 0.9209 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.50 | 770.25 | 1236 | 1497 | 0.8255 | 0.6375 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 14.50 | 770.25 | 1439 | 1497 | 0.9611 | 0.9189 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.73 | 770.25 | 1287 | 1664 | 0.7732 | 0.5869 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 16.73 | 770.25 | 1526 | 1664 | 0.9168 | 0.8497 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.95 | 770.25 | 1380 | 1832 | 0.7531 | 0.5942 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 18.95 | 770.25 | 1595 | 1832 | 0.8704 | 0.7899 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.17 | 770.25 | 1468 | 2008 | 0.7309 | 0.5943 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 21.17 | 770.25 | 1716 | 2008 | 0.8544 | 0.7849 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.39 | 770.25 | 1559 | 2244 | 0.6946 | 0.5793 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 23.39 | 770.25 | 1837 | 2244 | 0.8185 | 0.7565 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.62 | 770.25 | 1669 | 2514 | 0.6637 | 0.5730 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 25.62 | 770.25 | 1994 | 2514 | 0.7929 | 0.7458 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.84 | 770.25 | 1786 | 2833 | 0.6302 | 0.5644 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 27.84 | 770.25 | 2155 | 2833 | 0.7604 | 0.7288 | MN20160304_L02 | N04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.06 | 770.25 | 1911 | 3106 | 0.6152 | 0.5710 | MN20160304_L02 | K22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 30.06 | 770.25 | 2296 | 3106 | 0.7392 | 0.7210 | MN20160304_L02 | N04 |